SCHEMBL14489986

SCHEMBL14489986

C#Cc1cccc(Nc2ncnc3cc(OC)c(O[C@H]4CC[C@H](NC)CC4)cc23)c1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 16/20 0.74
GAK O14976 3/20 0.74
FBP1 P09467 2/20 0.74
ALDH1A1 P00352 1/20 0.74
MAPT P10636 1/20 0.74
ERBB2 P04626 6/20 0.60
KDR P35968 4/20 0.60
RET P07949 3/20 0.60
ABCG2 Q9UNQ0 2/20 0.60
ILK Q13418 2/20 0.60
RIPK2 O43353 2/20 0.60
BUB1 O43683 2/20 0.60
STK10 O94804 2/20 0.60
ABL1 P00519 2/20 0.60
LCK P06239 2/20 0.60
LYN P07948 2/20 0.60
SRC P12931 2/20 0.60
FGFR2 P21802 2/20 0.60
FECH P22830 2/20 0.60
FLT3 P36888 2/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14489984 1.00 EGFR (0.74) EGFRGAKFBP1ALDH1A1MAPT
SCHEMBL14489992 0.90 EGFR (0.75) EGFRGAKFBP1ALDH1A1MAPT
SCHEMBL14489989 0.90 EGFR (0.75) EGFRGAKFBP1ALDH1A1MAPT
SCHEMBL14489959 0.89 EGFR (0.68) EGFRGAKFBP1ALDH1A1MAPT
SCHEMBL14489961 0.89 EGFR (0.68) EGFRGAKFBP1ALDH1A1MAPT
SCHEMBL209715 0.89 EGFR (0.75) EGFRGAKFBP1ALDH1A1MAPT
SCHEMBL29623603 0.89 EGFR (0.75) EGFRGAKFBP1ALDH1A1MAPT
SCHEMBL185543 0.89 EGFR (0.75) EGFRGAKFBP1ALDH1A1MAPT
Hydrochloric Acid SCHEMBL4085852 0.88 EGFR (0.74) EGFRGAKFBP1ALDH1A1MAPT
Hydrochloric Acid SCHEMBL1446303 0.88 EGFR (0.74) EGFRGAKFBP1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007068552-A1 BICYCLIC HETEROCYCLES, MEDICAMENTS CONTAINING SAID COMPOUNDS, USE THEREOF, AND METHOD FOR THE PRODUCTION THEREOF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-06-21 WO disclosed
US-20070135463-A1 Bicyclic heterocycles, drugs containing said compounds, the use thereof and method for preparing same HIMMELSBACH FRANK 2007-06-14 US disclosed
US-20070135463-A1 Bicyclic heterocycles, drugs containing said compounds, the use thereof and method for preparing same HIMMELSBACH FRANK 2007-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135463-A1 Bicyclic heterocycles, drugs containing said compounds, the use thereof and method for preparing same BPHL, CYP11B2, CYP11B1 EGFR 349/4885GAK 824/4885FBP1 1088/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.